Stealth anticancer nanoparticles made from mussel proteins that 'lie in wait and attack only cancer cells'
Researchers in South Korea have created nanoparticles made from mussel proteins that remain inactive in healthy tissue but release anticancer drugs specifically in tumor environments. This targeted approach may reduce treatment side effects and improve effectiveness for pancreatic cancer, which is typically hard to treat and often diagnosed late. The technology uses the unique properties of mussel proteins to respond to the specific conditions found in tumors.
Scientists in South Korea have created nanoparticles made from mussel proteins that stay hidden in healthy tissue and release cancer drugs only when they reach tumor cells.
This technology could make cancer treatments more precise, reducing harm to healthy cells and increasing the effectiveness of drugs against pancreatic cancer.
This innovation shows how nature-inspired materials can be used to create more targeted and less harmful medical treatments, offering hope for better cancer care.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.